24.04.24 | Vollzeit | Lüneburg | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory and anti-inflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main
Später ansehen19.04.24 | Vollzeit | Potsdam | dormakaba Deutschland GmbHWe are at the heart of every place that matters. As a leading global provider in the access solutions market for schools, banks, airports, hospitals, hotels, and many more, we enable seamless movement within secure, safe, and sustainable places. Our work is IMPORTANT. YOU are important. We
Später ansehen07.04.24 | Vollzeit | Hildesheim | JobLeads GmbH | 100.000 € - 125.000 € Mit Hauptsitz in Hildesheim ist Teil der ResMed Corp. und beschäftigt derzeit über 700 Mitarbeitende an neun Standorten bundesweit. Wir sind ein Unternehmen mit starken Werten wie Teamgeist, Kundenorientierung und Leidenschaft, das täglich an zukunftsweisenden Softwarelösungen sowie Services
Später ansehen10.04.24 | Vollzeit | Winsen (Luhe) | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Winsen (Luhe) | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Winsen (Luhe) | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Winsen (Luhe) | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Winsen (Luhe) | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Winsen (Luhe) | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Hospital Service in Niedersachsen Bundesland kostenlos abonnieren.